[Congressional Bills 118th Congress]
[From the U.S. Government Publishing Office]
[H.R. 4421 Introduced in House (IH)]

<DOC>






118th CONGRESS
  1st Session
                                H. R. 4421

  To reauthorize certain programs under the Public Health Service Act 
with respect to public health security and all-hazards preparedness and 
 response related to the Administration for Strategic Preparedness and 
                   Response, and for other purposes.


_______________________________________________________________________


                    IN THE HOUSE OF REPRESENTATIVES

                             June 30, 2023

  Mr. Hudson introduced the following bill; which was referred to the 
                    Committee on Energy and Commerce

_______________________________________________________________________

                                 A BILL


 
  To reauthorize certain programs under the Public Health Service Act 
with respect to public health security and all-hazards preparedness and 
 response related to the Administration for Strategic Preparedness and 
                   Response, and for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. SHORT TITLE; TABLE OF CONTENTS.

    (a) Short Title.--This Act may be cited as the ``Preparing for All 
Hazards and Pathogens Reauthorization Act''.
    (b) Table of Contents.--The table of contents for this Act is as 
follows:

Sec. 1. Short title; table of contents.
TITLE I--PREPARING FOR AND RESPONDING TO PUBLIC HEALTH SECURITY THREATS

Sec. 101. National health security strategy.
Sec. 102. Protection of national security from threats.
Sec. 103. Public Health Emergency Medical Countermeasures Enterprise.
Sec. 104. Partnerships for State and regional hospital preparedness to 
                            improve surge capacity.
Sec. 105. Guidelines for regional health care emergency preparedness 
                            and response systems.
Sec. 106. Strategic National Stockpile.
Sec. 107. Diagnostic testing preparedness plan.
Sec. 108. Biomedical advanced research and development authority.
Sec. 109. Ensuring collaboration and coordination in medical 
                            countermeasure development.
Sec. 110. Review of ASPR efforts to ensure supply chain resiliency and 
                            accountability.
Sec. 111. Review of HHS efforts to ensure rapid production and domestic 
                            manufacturing capacity of medical 
                            countermeasures.
Sec. 112. Crisis standards of care.
   TITLE II--ENSURING WORKFORCE TO PREPARE FOR AND RESPOND TO PUBLIC 
                        HEALTH SECURITY THREATS

Sec. 201. Emergency system for advance registration of volunteer health 
                            professional.
Sec. 202. Military and civilian partnership for trauma readiness.
Sec. 203. National advisory committees on disasters.
Sec. 204. National Disaster Medical System.
Sec. 205. Volunteer Medical Reserve Corps.

TITLE I--PREPARING FOR AND RESPONDING TO PUBLIC HEALTH SECURITY THREATS

SEC. 101. NATIONAL HEALTH SECURITY STRATEGY.

    (a) Public Health Workforce.--Section 2802(a)(3) of the Public 
Health Service Act (42 U.S.C. 300hh-1(a)(3)) is amended by striking 
``In 2022, the'' and inserting ``The''.
    (b) Medical and Public Health Community Preparedness Goal.--Section 
2802(b)(8)(A) of the Public Health Service Act (42 U.S.C. 300hh-
1(b)(8)(A)) is amended by inserting before the semicolon the following: 
``, including by protecting against cybersecurity threats''.

SEC. 102. PROTECTION OF NATIONAL SECURITY FROM THREATS.

    Section 2811(f)(2)(A) of the Public Health Service Act (42 U.S.C. 
300hh-10(f)(2)(A)) is amended by striking ``$250,000,000 for each of 
fiscal years 2019 through 2023'' and inserting ``$327,991,000 for each 
of fiscal years 2024 through 2028''.

SEC. 103. PUBLIC HEALTH EMERGENCY MEDICAL COUNTERMEASURES ENTERPRISE.

    (a) Members.--Section 2811-1(b) of the Public Health Service Act 
(42 U.S.C. 30hh-10a(b)) is amended by striking paragraph (11) and 
inserting the following:
            ``(11) The Director of the Biomedical Advanced Research and 
        Development Authority.
            ``(12) The Director of the Strategic National Stockpile.
            ``(13) Representatives of any other Federal agency, which 
        may include the Director of the National Institute of Allergy 
        and Infectious Diseases and the Director of the Office of 
        Public Health Preparedness and Response, as the Secretary 
        determines appropriate.''.
    (b) Functions.--Section 2811-1(c)(2) of the Public Health Service 
Act (42 U.S.C. 30hh-10a(c)(2)) is amended to read as follows:
            ``(2) Input.--In carrying out this section, the PHEMCE 
        shall solicit and consider input from--
                    ``(A) the PHEMCE Advisory Committee maintained 
                under subsection (d), as appropriate; and
                    ``(B) State, local, Tribal, and territorial public 
                health departments or officials, as appropriate.''.
    (c) Advisory Committee.--Section 2811-1 of the Public Health 
Service Act (42 U.S.C. 30hh-10a) is amended by adding at the end the 
following:
    ``(d) PHEMCE Advisory Committee.--
            ``(1) Establishment.--The Secretary shall--
                    ``(A) establish and maintain an advisory committee 
                to be known as the PHEMCE Advisory Committee (in this 
                subsection referred to as the `Advisory Committee') to 
                seek input and ensure communication and transparency in 
                the functions of the PHEMCE; and
                    ``(B) seek input from and consult with external 
                partners with divergent threat portfolios, including 
                chemical, biological, radiological, or nuclear agents 
                and emerging infectious diseases, to ensure the right 
                combination of threat-specific expertise on PHEMCE 
                functions under subsection (c)(1) and to ensure 
                appropriate capability and capacity to maintain overall 
                readiness.
            ``(2) Duties.--The Advisory Committee shall--
                    ``(A) provide advice to the PHEMCE in carrying out 
                its functions;
                    ``(B) solicit and incorporate the input of the 
                private sector, non-Federal partners, and stakeholders 
                to increase communication and transparency, identify 
                gaps of preparedness, and coordinate improvements in 
                PHEMCE decision-making;
                    ``(C) aid in the PHEMCE's strategic planning and 
                decision-making regarding medical countermeasure 
                research, advanced research, development, procurement, 
                stockpiling, replenishment, deployment, and 
                distribution;
                    ``(D) aid in interactions among the PHEMCE's 
                members listed in subsection (b) and other government 
                entities; and
                    ``(E) aid in the PHEMCE's communication of 
                decisions related to the PHEMCE's functions.
            ``(3) Membership.--The Secretary, in consultation with the 
        members of the PHEMCE listed in subsection (b), shall appoint 
        to the Advisory Committee at least 9, and not more than 15, 
        individuals, including--
                    ``(A) at least 3 non-Federal professionals with 
                expertise in medical countermeasure development, 
                including medical countermeasures for chemical, 
                biological, radiological, or nuclear agents and 
                emerging infectious diseases;
                    ``(B) at least 2 non-Federal professionals with 
                expertise in medical countermeasure stockpiling and 
                replenishment;
                    ``(C) at least 2 non-Federal professionals with 
                expertise in the medical countermeasure supply chain, 
                including medical countermeasure manufacturing and 
                distribution;
                    ``(D) at least 2 non-Federal professionals with 
                expertise in medical disaster planning, preparedness, 
                response, or recovery;
                    ``(E) 1 non-Federal professional appointed by the 
                Speaker of the House of Representatives;
                    ``(F) 1 non-Federal professional appointed by the 
                minority leader of the House of Representatives;
                    ``(G) 1 non-Federal professional appointed by the 
                majority leader of the Senate; and
                    ``(H) 1 non-Federal professional appointed by the 
                minority leader of the Senate.
            ``(4) Term of appointment.--Each member of the Advisory 
        Committee shall be appointed for a term of 2 years and may be 
        reappointed for two additional terms of 2 years, for a total of 
        not more than 6 years. The first and second such terms may be 
        consecutive. The third such term may not be consecutive.
            ``(5) Meetings.--The Advisory Committee shall--
                    ``(A) meet not less than 4 times in each calendar 
                year that begins after the establishment of the 
                Advisory Committee;
                    ``(B) hold all meetings in-person;
                    ``(C) for purposes of ensuring transparency, 
                provide adequate advance notice of the date of each 
                meeting, including by publicly posting the meeting date 
                30 days before the date on which the meeting is to be 
                held;
                    ``(D) not later than 60 days after each meeting, 
                communicate the activities carried out and decisions 
                made during, and minutes of, such meeting to the 
                appropriate congressional committees; and
                    ``(E) not later than 30 days after each meeting, 
                communicate the activities carried out and decisions 
                made during, and minutes of, such meeting to the 
                PHEMCE.''.

SEC. 104. PARTNERSHIPS FOR STATE AND REGIONAL HOSPITAL PREPAREDNESS TO 
              IMPROVE SURGE CAPACITY.

    (a) Authorization of Appropriations.--Section 319C-2(j)(1)(A) of 
the Public Health Service Act (42 U.S.C. 247d-3b(j)(1)(A)) is amended 
by striking ``2019 through 2023'' and inserting ``2024 through 2028''.
    (b) Sunset.--Section 319C-2(j)(1)(B)(iii) of the Public Health 
Service Act (42 U.S.C. 247d-3b(j)(1)(B)(iii)) is amended by striking 
``2023'' and inserting ``2028''.

SEC. 105. GUIDELINES FOR REGIONAL HEALTH CARE EMERGENCY PREPAREDNESS 
              AND RESPONSE SYSTEMS.

    (a) Guidelines.--Section 319C-3(b)(3) of the Public Health Service 
Act (42 U.S.C. 247d-3c(b)(3)) is amended by striking ``the Pandemic and 
All-Hazards Preparedness and Advancing Innovation Act of 2019 
(including any amendments made by such Act)'' and inserting ``the 
Pandemic and All-Hazards Preparedness and Advancing Innovation Act of 
2019, the PREVENT Pandemics Act (title II of division FF of Public Law 
117-328), and the Preparing for All Hazards and Pathogens 
Reauthorization Act''.
    (b) Demonstration Project for Regional Health Care Preparedness and 
Response Systems.--Section 319C-3(e)(2) of the Public Health Service 
Act (42 U.S.C. 247d-3c(e)(2)) is amended by striking ``2023'' and 
inserting ``2028''.

SEC. 106. STRATEGIC NATIONAL STOCKPILE.

    (a) Responsibility for Administering the Strategic National 
Stockpile.--
            (1) Transfer.--
                    (A) In general.--Section 319F-2(a)(1) of the Public 
                Health Service Act (42 U.S.C. 247d-6b(a)(1)) is amended 
                by striking ``The Secretary, in collaboration with the 
                Assistant Secretary for Preparedness and Response and 
                the Director of the Centers for Disease Control and 
                Prevention, and in coordination with the Secretary of 
                Homeland Security'' and inserting ``The Secretary, 
                acting through the Assistant Secretary for Preparedness 
                and Response, in coordination with the Director of the 
                Centers for Disease Control and Prevention and the 
                Secretary of Homeland Security''.
                    (B) Conforming amendment.--Section 319F-2(a)(3)(E) 
                of the Public Health Service Act (42 U.S.C. 247d-
                6b(a)(3)(E)) is amended by striking ``the Assistant 
                Secretary for Preparedness and Response,''.
                    (C) Pilot program to support state medical 
                stockpiles.--Section 319F-2(i)(1) of the Public Health 
                Service Act (42 U.S.C. 247d-6b(i)(1)) is amended by 
                striking ``The Secretary, in consultation with the 
                Assistant Secretary for Preparedness and Response and 
                the Director of the Centers for Disease Control and 
                Prevention'' and inserting ``The Secretary, acting 
                through the Assistant Secretary for Preparedness and 
                Response, in consultation with the Director of the 
                Centers for Disease Control and Prevention''.
                    (D) Transition.--The Secretary of Health and Human 
                Services shall take such actions as may be necessary to 
                ensure that, not later than 180 days after the date of 
                enactment of this Act, the amendments made by this 
                subsection are fully implemented, including any 
                necessary transfer of personnel and resources.
            (2) ASPR authorities.--
                    (A) Additional coordination duty.--Section 
                2811(b)(4) of the Public Health Service Act (42 U.S.C. 
                247d-6b(b)) is amended by adding at the end the 
                following:
                    ``(K) Strategic national stockpile.--Coordinate 
                with the Director of the Centers for Disease Control 
                and Prevention and the Secretary of Homeland Security 
                regarding the maintenance and operation of, and 
                procurement and contracting related to, the Strategic 
                National Stockpile under section 319F-2.''.
                    (B) Additional responsibility.--
                            (i) In general.--Section 2811(c)(2) of the 
                        Public Health Service Act (42 U.S.C. 247d-
                        6b(c)(2)) is amended--
                                    (I) by redesignating subparagraphs 
                                (E) and (F) as subparagraphs (F) and 
                                (G), respectively; and
                                    (II) by inserting after 
                                subparagraph (D) the following:
                    ``(E) the Strategic National Stockpile pursuant to 
                section 319F-2;''.
                            (ii) Conforming changes.--Section 
                        2811(c)(3) of the Public Health Service Act (42 
                        U.S.C. 247d-6b(c)(3)) is amended--
                                    (I) in subparagraph (A), by 
                                inserting ``and'' after the semicolon;
                                    (II) by striking subparagraph (B); 
                                and
                                    (III) by redesignating subparagraph 
                                (C) as subparagraph (B).
    (b) Vendor-Managed Inventory and Warm-Based Surge Capacity 
Contracts and Cooperative Agreements With Clinical Laboratories.--
Section 319F-2(a)(5)(A) of the Public Health Service Act (42 U.S.C. 
247d-6b(a)(5)(A)) is amended--
            (1) by inserting after ``contracts or cooperative 
        agreements with vendors, which may include manufacturers or 
        distributors of medical products,'' the following: ``as well as 
        clinical laboratories,''; and
            (2) in clause (ii), by striking ``domestic manufacturing 
        capacity'' and inserting ``domestic manufacturing and 
        laboratory capacity''.
    (c) Contract Notification.--Section 319F-2(a) of the Public Health 
Service Act (42 U.S.C. 247d-6b(a)) is amended by adding at the end the 
following:
            ``(8) Procurement contract duration.--
                    ``(A) In general.--A contract for the procurement 
                of a drug, vaccine or other biological product, medical 
                device, or other supplies for the stockpile under 
                paragraph (1) shall be for a period not to exceed five 
                years, except that, in first awarding the contract, the 
                Secretary may provide for a longer duration, not 
                exceeding 10 years, if the Secretary determines that 
                complexities or other difficulties in performance under 
                the contract justify such a period. The contract shall 
                be renewable for additional periods, none of which 
                shall exceed five years.
                    ``(B) Notification.--The Secretary shall notify--
                            ``(i) the Committee on Appropriations and 
                        the Committee on Energy and Commerce of the 
                        House of Representatives and the Committee on 
                        Appropriations and the Committee on Health, 
                        Education, Labor, and Pensions of the Senate 
                        upon a determination by the Secretary to 
                        modify, renew, extend, or terminate a contract 
                        referred to in subparagraph (A); and
                            ``(ii) the relevant vendor within 90 days 
                        of a determination by the Secretary to modify, 
                        renew, extend, or terminate such a contract.''.
    (d) Authorization of Appropriations.--
            (1) In general.--Section 319F-2(f) of the Public Health 
        Service Act (42 U.S.C. 247d-6b(f)) is amended--
                    (A) in paragraph (1), by striking ``$610,000,000 
                for each of fiscal years 2019 through 2021, and 
                $750,000,000 for each of fiscal years 2022 and 2023'' 
                and inserting ``$965,000,000 for each of fiscal years 
                2024 through 2028'';
                    (B) by striking paragraph (2); and
                    (C) by striking ``Authorization of Appropriations'' 
                and all that follows through ``For the purpose of 
                carrying out subsection (a), there are authorized to be 
                appropriated'' and inserting ``Authorization of 
                Appropriations.--For the purpose of carrying out 
                subsection (a), there is authorized to be 
                appropriated''.
            (2) Pilot program to support state medical stockpiles.--
        Section 319F-2(i)(9) of the Public Health Service Act (42 
        U.S.C. 247d-6b(i)(9)) is amended by striking ``2024'' and 
        inserting ``2028''.

SEC. 107. DIAGNOSTIC TESTING PREPAREDNESS PLAN.

    The Public Health Service Act (42 U.S.C. 201 et seq.) is amended by 
inserting after section 319F-5 of such Act (42 U.S.C. 247d-6f) the 
following:

``SEC. 319F-6. DIAGNOSTIC TESTING PREPAREDNESS PLAN.

    ``(a) In General.--The Secretary, acting through the Assistant 
Secretary for Preparedness and Response, and in consultation with the 
heads of relevant Federal agencies, shall develop not later than 1 year 
after the date of enactment of this section and update not less than 
every 3 years thereafter a plan for rapid development, authorization, 
scaling, procurement, and distribution of diagnostics and clinical and 
diagnostic laboratory testing capacity during a public health emergency 
declared under section 319.
    ``(b) Purposes.--The purposes of the plan under subsection (a) 
shall be--
            ``(1) to facilitate the development and utilization of 
        diagnostics for use with respect to a novel chemical, 
        biological, radiological, or nuclear threat or an emerging 
        infectious disease, including any such high-throughput 
        laboratory diagnostic, point-of-care diagnostic, or rapid at-
        home or point-of-use diagnostic; and
            ``(2) to describe the processes for rapid development, 
        authorization, scaling, procurement, and distribution of 
        diagnostics and clinical and diagnostic laboratory testing 
        capacity.
    ``(c) Public-Private Coordination.--
            ``(1) In general.--The Secretary, acting through the 
        Assistant Secretary for Preparedness and Response, shall 
        include within the plan under subsection (a) a plan for public-
        private coordination on national diagnostic testing during a 
        public health emergency.
            ``(2) Contents.--The plan under paragraph (1) shall be 
        designed to facilitate coordination and collaboration among--
                    ``(A) government agencies; and
                    ``(B) critical private-sector diagnostic testing 
                stakeholders, including private-sector clinical and 
                diagnostic laboratories, diagnostic manufacturers, 
                health care product distributors, and research 
                laboratories.
    ``(d) Public Availability.--The Secretary, acting through the 
Assistant Secretary for Preparedness and Response, shall make the plan 
under subsection (a) publicly available.
    ``(e) Reports to Congress.--Not later than 1 year after commencing 
implementation of the plan under subsection (a) for a public health 
emergency, the Secretary, acting through the Assistant Secretary for 
Preparedness and Response, shall submit to the Congress a report 
evaluating the effectiveness of activities implemented under the 
plan.''.

SEC. 108. BIOMEDICAL ADVANCED RESEARCH AND DEVELOPMENT AUTHORITY.

    (a) Medical Countermeasures for Viral Threats With Pandemic 
Potential.--Section 319L(c)(4) of the Public Health Service Act (42 
U.S.C. 247d-7e(c)(4)) is amended--
            (1) in subparagraph (D)--
                    (A) in clause (ii), by striking ``; and'' and 
                inserting a semicolon;
                    (B) by redesignating clause (iii) as clause (v); 
                and
                    (C) by inserting after clause (ii) the following:
                            ``(iii) the identification and development 
                        of platform manufacturing technologies needed 
                        for advanced development and manufacturing of 
                        medical countermeasures for viral families 
                        which have significant potential to cause a 
                        pandemic;
                            ``(iv) advanced research and development of 
                        flexible medical countermeasures against 
                        priority respiratory virus families and other 
                        respiratory viral pathogens with a significant 
                        potential to cause a pandemic, with both 
                        pathogen-specific and pathogen-agnostic 
                        approaches; and''; and
            (2) in subparagraph (F)--
                    (A) in clause (ii), by striking ``; and'' at the 
                end and inserting a semicolon;
                    (B) in clause (iii), by striking the period and 
                inserting ``; and''; and
                    (C) by adding at the end the following:
                            ``(iv) priority virus families and other 
                        viral pathogens with a significant potential to 
                        cause a pandemic.''.
    (b) Contract Notification.--Section 319L(c)(5) of the Public Health 
Service Act (42 U.S.C. 247d-7e(c)(5)) is amended by adding at the end 
the following:
                    ``(I) Duration.--A contract, grant, cooperative 
                agreement, or other transaction entered into under this 
                section shall be for a period not to exceed five years, 
                except that, in first awarding the grant or entering 
                into the contract, cooperative agreement, or other 
                transaction, the Secretary may provide for a longer 
                duration, not exceeding 10 years, if the Secretary 
                determines that complexities or other difficulties in 
                performance under the contract, grant, cooperative 
                agreement, or other transaction justify such a period. 
                The contract, grant, cooperative agreement, or other 
                transaction shall be renewable for additional periods, 
                none of which shall exceed five years. The Secretary 
                shall notify the vendor within 90 days of a 
                determination by the Secretary to modify, renew, 
                extend, or terminate such contract, grant, cooperative 
                agreement, or other transaction.''.
    (c) Authorization of Appropriations.--Section 319L(d)(2) of the 
Public Health Service Act (42 U.S.C. 247d-7e(d)(2)) is amended by 
striking ``$611,700,000 for each of fiscal years 2019 through 2023'' 
and inserting ``$950,000,000 for each of fiscal years 2024 through 
2028''.
    (d) Inapplicability of Certain Provisions Sunset.--Section 
319L(e)(1)(D) of the Public Health Service Act (42 U.S.C. 247d-
7e(e)(1)(D)) is amended by striking ``on the date that is 17 years 
after the date of enactment of the Pandemic and All-Hazards 
Preparedness Act'' and inserting ``on October 1, 2028''.

SEC. 109. ENSURING COLLABORATION AND COORDINATION IN MEDICAL 
              COUNTERMEASURE DEVELOPMENT.

    Section 319L-1(b) of the Public Health Service Act (42 U.S.C. 274d-
7f(b)) is amended by striking ``at the end of the 17-year period that 
begins on the date of enactment of this Act'' and inserting ``on 
October 1, 2028''.

SEC. 110. REVIEW OF ASPR EFFORTS TO ENSURE SUPPLY CHAIN RESILIENCY AND 
              ACCOUNTABILITY.

    (a) In General.--Not later than 18 months after the date of 
enactment of this Act, the Comptroller General of the United States 
shall complete a review of--
            (1) the Supply Chain Control Tower Program (in this section 
        referred to as the ``SCCT Program'') under the Administration 
        for Strategic Preparedness and Response of the Department of 
        Health and Human Services; and
            (2) any related efforts of the Administration for Strategic 
        Preparedness and Response--
                    (A) to create supply chain visibility into 
                inventory, capacity, and distribution flow of certain 
                products critical to preparedness and response efforts;
                    (B) to provide insights into demand forecasting and 
                modeling of certain products critical to preparedness 
                and response efforts; or
                    (C) to inform preparedness and response efforts by 
                targeting distribution and coordinating supply with 
                demand for certain products critical to preparedness 
                and response efforts.
    (b) Issues.--The review under this section shall include 
examination of--
            (1) the data being collected and maintained pursuant to the 
        SCCT Program;
            (2) how the Department of Health and Human Services, acting 
        through the Administration for Strategic Preparedness and 
        Response, uses such data to provide supply chain visibility and 
        address actual or potential supply gaps;
            (3) the extent to which such data is provided and shared 
        with end users, including States, localities, Territories, 
        Tribes, and industry partners;
            (4) the frequency and cadence of data reporting and sharing 
        by and among States, localities, Territories, Tribes, and 
        industry partners;
            (5) information related to the type and number of States, 
        localities, Territories, Tribes, and industry partners 
        participating in the SCCT Program;
            (6) the process by which States, localities, Territories, 
        Tribes, and industry partners voluntarily choose to participate 
        in the SCCT Program; and
            (7) any inefficiencies, deficiencies, or challenges related 
        to the application or operation of the SCCT Program.
    (c) Report to Congress.--Not later than the deadline described in 
subsection (a) for the completion of the review under this section, the 
Comptroller General shall submit to the Committee on Energy and 
Commerce of the House of Representatives and the Committee on Health, 
Education, Labor, and Pensions of the Senate a report on the results of 
such review.

SEC. 111. REVIEW OF HHS EFFORTS TO ENSURE RAPID PRODUCTION AND DOMESTIC 
              MANUFACTURING CAPACITY OF MEDICAL COUNTERMEASURES.

    (a) In General.--Not later than 1 year after the date of the 
enactment of this Act, the Comptroller General of the United States 
shall conduct and complete a review examining the efforts of the 
Secretary of Health and Human Services to ensure that the United States 
is prepared to rapidly produce qualified countermeasures (as defined in 
section 319F-1 of the Public Health Service Act (42 U.S.C. 247d-6a)) in 
the event of a public health emergency declared under section 319 of 
the Public Health Service Act (42 U.S.C. 274d).
    (b) Contents.--The review conducted under subsection (a) shall 
include a review of--
            (1) the efforts described in such subsection, including the 
        Secretary's efforts to transition from the Centers for 
        Innovation and Advanced Drug Manufacturing program to any new 
        efforts, including the National Biopharmaceutical Manufacturing 
        Partnership and Industrial Base Expansion Connect;
            (2) the progress made toward the implementation of such 
        efforts; and
            (3) the planning within the Department of Health and Human 
        Services to assess risks and challenges associated with 
        advanced development and manufacturing of qualified 
        countermeasures.
    (c) Report to Congress.--Not later than 1 year after completing the 
review under subsection (a), the Comptroller General of the United 
States shall submit to the Congress a report containing--
            (1) the results of the review; and
            (2) the Comptroller General's recommendations for ensuring 
        that the United States is prepared to rapidly produce qualified 
        countermeasures in the event of a public health emergency.

SEC. 112. CRISIS STANDARDS OF CARE.

    Not later than 2 years after the date of enactment of this Act, the 
Secretary of Health and Human Services, acting through the Director of 
the Office for Civil Rights of the Department of Health and Human 
Services, shall issue guidance on how to develop or modify State and 
local crisis standards of care for use during an emergency period (as 
defined in section 1135(g)(1) of the Social Security Act (42 U.S.C. 
1320b-5(g)(1))) so as to bring such standards of care into compliance 
with the nondiscrimination requirements of section 504 of the 
Rehabilitation Act of 1973 (29 U.S.C. 794).

   TITLE II--ENSURING WORKFORCE TO PREPARE FOR AND RESPOND TO PUBLIC 
                        HEALTH SECURITY THREATS

SEC. 201. EMERGENCY SYSTEM FOR ADVANCE REGISTRATION OF VOLUNTEER HEALTH 
              PROFESSIONAL.

    (a) In General.--Section 319I(a) of the Public Health Service Act 
(42 U.S.C. 247d-7b) is amended by striking ``Not later than 12 months 
after the date of enactment of the Pandemic and All-Hazards 
Preparedness Act, the Secretary shall link existing State verification 
systems to maintain'' and inserting ``The Secretary shall continue to 
maintain''.
    (b) Authorization of Appropriations.--Section 319I(k) of the Public 
Health Service Act (42 U.S.C. 247d-7b(k)) is amended by striking ``2019 
through 2023'' and inserting ``2024 through 2028''.

SEC. 202. MILITARY AND CIVILIAN PARTNERSHIP FOR TRAUMA READINESS.

    Section 1291(g) of the Public Health Service Act (42 U.S.C. 300d-
91(g)) is amended by striking ``2019 through 2023'' and inserting 
``2024 through 2028''.

SEC. 203. NATIONAL ADVISORY COMMITTEES ON DISASTERS.

    (a) National Advisory Committee on Children and Disasters.--
Subsection (g) of section 2811A of the Public Health Service Act (42 
U.S.C. 300hh-10b) is amended to read as follows:
    ``(g) Sunset.--
            ``(1) In general.--The Advisory Committee shall terminate 
        on September 30, 2028.
            ``(2) Extension of committee.--Not later than October 1, 
        2027, the Secretary shall submit to Congress a recommendation 
        on whether the Advisory Committee should be extended.''.
    (b) National Advisory Committee on Seniors and Disasters.--Section 
2811B of the Public Health Service Act (42 U.S.C. 300hh-10c) is 
amended--
            (1) in subsection (d)--
                    (A) in paragraph (1), by striking ``in consultation 
                with such other heads of agencies as appropriate, shall 
                appoint not more than 17 members'' and inserting ``in 
                consultation with such other Secretaries as may be 
                appropriate, shall appoint not more than 23 members'';
                    (B) by redesignating paragraph (2) as paragraph 
                (3);
                    (C) by amending paragraph (3), as so redesignated--
                            (i) in the paragraph heading, by striking 
                        ``Required members'' and inserting ``Required 
                        federal members'';
                            (ii) in the matter preceding subparagraph 
                        (A), by striking ``and non-Federal members,'';
                            (iii) by striking subparagraphs (J) and 
                        (K); and
                            (iv) by redesignating subparagraph (L) as 
                        subparagraph (J);
                    (D) by inserting after paragraph (1) the following 
                new paragraph:
            ``(2) Required non-federal members.--The Secretary, in 
        consultation with such other heads of Federal agencies as may 
        be appropriate, shall appoint to the Advisory Committee under 
        paragraph (1) at least 13 individuals, including--
                    ``(A) at least 4 non-Federal health care providers 
                with expertise in geriatric medical disaster planning, 
                preparedness, response, or recovery;
                    ``(B) at least 3 representatives of State, local, 
                Tribal, or territorial agencies with expertise in 
                geriatric disaster planning, preparedness, response, or 
                recovery; and
                    ``(C) at least 4 non-Federal professionals with 
                training in gerontology, including social workers, 
                scientists, human services specialists, or other non-
                medical professionals, with experience in disaster 
                planning, preparedness, response, or recovery among 
                other adults.''; and
                    (E) by adding at the end the following new 
                paragraphs:
            ``(4) Term of appointment.--Each member of the Advisory 
        Committee appointed under paragraph (2) shall serve for a term 
        of 3 years, except that the Secretary may adjust the terms of 
        the Advisory Committee appointees serving on the date of 
        enactment of the Preparing for All Hazards and Pathogens 
        Reauthorization Act, or appointees who are initially appointed 
        after such date of enactment, in order to provide for a 
        staggered term of appointment for all members.
            ``(5) Consecutive appointments; maximum terms.--A member 
        appointed under paragraph (2) may serve not more than 3 terms 
        on the Advisory Committee, and not more than 2 of such terms 
        may be served consecutively.''; and
            (2) in subsection (g)--
                    (A) in paragraph (1), by striking ``2023'' and 
                inserting ``2028''; and
                    (B) in paragraph (2), by striking ``2022'' and 
                inserting ``2027''.
    (c) National Advisory Committee on Individuals With Disabilities.--
Section 2811C of the Public Health Service Act (42 U.S.C. 300hh-10d) is 
amended--
            (1) by redesignating subsections (c) through (g) as 
        subsections (d) through (h), respectively;
            (2) by inserting after subsection (b) the following new 
        subsection:
    ``(c) Additional Duties.--The Advisory Committee may provide advice 
and recommendations to the Secretary with respect to individuals with 
disabilities, and medical and public health grants and cooperative 
agreements, as applicable to preparedness and response activities under 
this title and title III.'';
            (3) in subsection (d), as so redesignated--
                    (A) in paragraph (1), by striking ``in consultation 
                with such other heads of agencies and departments as 
                appropriate, shall appoint not more than 17 members'' 
                and inserting ``in consultation with such other 
                Secretaries as may be appropriate, shall appoint not 
                more than 23 members'';
                    (B) by redesignating paragraph (2) as paragraph 
                (3);
                    (C) by amending paragraph (3), as redesignated--
                            (i) in the paragraph heading, by striking 
                        ``Required members'' and inserting ``Required 
                        federal members'';
                            (ii) in the matter preceding subparagraph 
                        (A), by striking ``and non-Federal members,'';
                            (iii) by striking subparagraph (K) and 
                        inserting the following:
                    ``(K) Representatives of such other Federal 
                agencies as the Secretary determines necessary to 
                fulfill the duties of the Advisory Committee.''; and
                            (iv) by striking subparagraphs (L) and (M);
                    (D) by inserting after paragraph (1) the following 
                new paragraph:
            ``(2) Required non-federal members.--The Secretary, in 
        consultation with such other heads of Federal agencies as may 
        be appropriate, shall appoint to the Advisory Committee under 
        paragraph (1) at least 13 individuals, including--
                    ``(A) at least 4 non-Federal health care 
                professionals with expertise in disability 
                accessibility before, during, and after disasters, 
                medical and mass care disaster planning, preparedness, 
                response, or recovery;
                    ``(B) at least 3 representatives from State, local, 
                Tribal, or territorial agencies with expertise in 
                disaster planning, preparedness, response, or recovery 
                for individuals with disabilities; and
                    ``(C) at least 4 individuals with a disability with 
                expertise in disaster planning, preparedness, response, 
                or recovery for individuals with disabilities.''; and
                    (E) by adding at the end the following new 
                paragraphs:
            ``(4) Term of appointment.--Each member of the Advisory 
        Committee appointed under paragraph (2) shall serve for a term 
        of 3 years, except that the Secretary may adjust the terms of 
        the Advisory Committee appointees serving on the date of 
        enactment of the Preparing for All Hazards and Pathogens 
        Reauthorization Act, or appointees who are initially appointed 
        after such date of enactment, in order to provide for a 
        staggered term of appointment for all members.
            ``(5) Consecutive appointments; maximum terms.--A member 
        appointed under paragraph (2) may serve not more than 3 terms 
        on the Advisory Committee, and not more than 2 of such terms 
        may be served consecutively.''; and
            (4) in subsection (g)--
                    (A) in paragraph (1), by striking ``2023'' and 
                inserting ``2028''; and
                    (B) in paragraph (2), by striking ``2022'' and 
                inserting ``2027''.

SEC. 204. NATIONAL DISASTER MEDICAL SYSTEM.

    (a) Elimination of Sunset of Authority To Make Certain Appointments 
for National Disaster Medical System.--Section 2812(c)(4) of the Public 
Health Service Act (42 U.S.C. 300hh-11(c)(4)) is amended--
            (1) by striking ``(A) in general.--If the Secretary 
        determines'' and inserting ``If the Secretary determines''; and
            (2) by striking subparagraph (B).
    (b) Authorization of Appropriations.--Section 2812(g) of the Public 
Health Service Act (42 U.S.C. 300hh-11(g)) is amended by striking 
``$57,400,000 for each of fiscal years 2019 through 2023'' and 
inserting ``$96,904,000 for each of fiscal years 2024 through 2028''.

SEC. 205. VOLUNTEER MEDICAL RESERVE CORPS.

    Section 2813(i) of the Public Health Service Act (42 U.S.C. 300hh-
15(i)) is amended by striking ``2019 through 2023'' and inserting 
``2024 through 2028''.
                                 <all>